Search Results - "Silva, Lais Teodoro da"
-
1
Using Dendritic Cell-Based Immunotherapy to Treat HIV: How Can This Strategy be Improved?
Published in Frontiers in immunology (18-12-2018)“…Harnessing dendritic cells (DC) to treat HIV infection is considered a key strategy to improve anti-HIV treatment and promote the discovery of functional or…”
Get full text
Journal Article -
2
Prevalence of anti-SARS-CoV-2 antibodies in outpatients of a large public university hospital in Sao Paulo, Brazil
Published in Revista do Instituto de Medicina Tropical de São Paulo (01-01-2020)“…Coronavirus disease 19 (COVID-19) is caused by SARS-Cov-2 and the manifestations of this infection range from an absence of symptoms all the way up to severe…”
Get full text
Journal Article -
3
SARS-CoV-2 recombinant proteins stimulate distinct cellular and humoral immune response profiles in samples from COVID-19 convalescent patients
Published in Clinics (São Paulo, Brazil) (01-01-2021)“…In this preliminary study we investigated cellular and humoral immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens in…”
Get full text
Journal Article -
4
Patient with agammaglobulinemia produces anti-SARS-CoV-2 reactive T-cells after CoronaVac vaccine
Published in Clinics (São Paulo, Brazil) (01-01-2022)Get full text
Journal Article -
5
Salivary, serological, and cellular immune response to the CoronaVac vaccine in health care workers with or without previous COVID-19
Published in Scientific reports (16-06-2022)“…We investigated the anti-SARS-CoV-2 post-vaccine response through serum and salivary antibodies, serum antibody neutralizing activity and cellular immune…”
Get full text
Journal Article -
6
Effects of Injectable Solutions on the Quality of Monocyte-Derived Dendritic Cells for Immunotherapy
Published in Journal of immunology research (07-06-2024)“…Therapeutic vaccines based on monocyte-derived dendritic cells have been shown to be promising strategies and may act as complementary treatments for viral…”
Get full text
Journal Article -
7
Phenotypic and functional profile of IFN-α-differentiated dendritic cells (IFN-DCs) from HIV-infected individuals
Published in Human vaccines & immunotherapeutics (02-09-2019)“…Dendritic cell (DC)-based immunotherapy is a promising strategy for the treatment of HIV-infected individuals. Different from the conventional protocol for DC…”
Get full text
Journal Article -
8
RESPOSTA CELULAR DE RESPONDEDORES E NÃO RESPONDEDORES ANTICÓRPICOS: ESTUDO EM PROFISSIONAIS DA SAÚDE VACINADOS COM CORONAVAC
Published in The Brazilian journal of infectious diseases (01-10-2023)“…Profissionais de saúde foram os indivíduos que sofreram constantemente os impactos da COVID-19 sendo considerados prioridade para a vacinação no Brasil. A…”
Get full text
Journal Article -
9
IMUNOFENOTIPAGEM DE LINFÓCITOS B EM RESPONDEDORES E NÃO RESPONDEDORES ANTICÓRPICOS: ESTUDO EM COORTE DE PROFISSIONAIS DA SAÚDE VACINADOS COM CORONAVAC
Published in The Brazilian journal of infectious diseases (01-10-2023)“…A COVID-19 gerou impactos constantes aos profissionais da saúde que estavam na linha de frente de combate, e deste modo foram considerados prioridade para a…”
Get full text
Journal Article -
10
Characterization of monocyte-derived dendritic cells used in immunotherapy for HIV-1-infected individuals
Published in Immunotherapy (01-08-2018)“…A therapeutic vaccine based on monocyte-derived dendritic cells (MDDCs) has been shown to represent a promising strategy for the treatment of cancer and viral…”
Get full text
Journal Article -
11
Autologous and allogenic systems of HIV expansion: what is the better choice for clinical application in therapeutic vaccine?
Published in Immunotherapy (01-12-2013)“…HIV-1 expanded in an allogenic system (Al-HIV) represents a cheaper and faster alternative to the autologous virus (Au-HIV) as an antigen in anti-HIV…”
Get more information
Journal Article -
12
Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial
Published in AIDS research and therapy (12-01-2022)“…We developed a personalized Monocyte-Derived Dendritic-cell Therapy (MDDCT) for HIV-infected individuals on suppressive antiretroviral treatment and evaluated…”
Get full text
Journal Article -
13
-
14